Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.1919
+0.0019 (1.00%)
Apr 23, 2026, 3:57 PM EST
Northwest Biotherapeutics Employees
Northwest Biotherapeutics had 25 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
25
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$13,124
Profits / Employee
-$560,448
Market Cap
315.93M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 25 | 0 | - | 25 | 0 |
| Dec 31, 2023 | 25 | 3 | 13.64% | 25 | 0 |
| Dec 31, 2022 | 22 | 3 | 15.79% | 22 | 0 |
| Dec 31, 2021 | 19 | 0 | - | 19 | 0 |
| Dec 31, 2020 | 19 | 2 | 11.76% | 19 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Silence Therapeutics | 88 |
| Vaxart | 65 |
| CytoDyn | 13 |
| Nuo Therapeutics | 10 |
| Harvard Apparatus Regenerative Technology | 8 |
| Provectus Biopharmaceuticals | 6 |
| Vicapsys Life Sciences | 2 |
| Cell Source | 1 |
Northwest Biotherapeutics News
- 2 days ago - Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic - PRNewsWire
- 5 months ago - Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility - PRNewsWire
- 6 months ago - Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed - PRNewsWire
- 8 months ago - Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd. - PRNewsWire
- 8 months ago - Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman - PRNewsWire
- 11 months ago - Northwest Biotherapeutics Announces Upcoming Presentation On Next Generation Dendritic Cells for Enhanced Anti-Tumor Treatments - PRNewsWire
- 1 year ago - Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing - PRNewsWire
- 1 year ago - Northwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews Strong Progress and Growth Opportunities - PRNewsWire